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Abstract
Background
Walking ability is an important prerequisite for activity, social participation and independent
living. While in most healthy adults, this ability can be assumed as given, limitations in walk-
ing ability occur with increasing age. Furthermore, slow walking speed is linked to several
chronic conditions and overall morbidity. Measurements of gait parameters can be used as
a proxy to detect functional decline and onset of chronic conditions. Up to now, gait charac-
teristics used for this purpose are measured in standardized laboratory settings. There is
some evidence, however, that long-term measurements of gait parameters in the living envi-
ronment have some advantages over short-term laboratory measurements.
Methods
We evaluated cross-sectional data from an accelerometric sensor worn in a subgroup of
554 participants of the Berlin Aging Study II (BASE-II). Data from the two BASE-II age
groups (age between 22–36 years and 60–79 years) were used for the current analysis of
accelerometric data for a minimum of two days and a maximum of ten days were available.
Real world walking speed, number of steps, maximum coherent distance and total distance
were derived as average data per day. Linear regression analyses were performed on the
different gait parameters in order to identify significant determinants. Additionally, Mann-
Whitney-U-tests were performed to detect sex-specific differences.
Results
Age showed to be significantly associated with real world walking speed and with the total
distance covered per day, while BMI contributed negatively to the number of walking steps,
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maximum coherent distance and total distance walked. Additionally, sex was associated
with walking steps. However, R2-values for all models were low. Overall, women had signifi-
cantly more walking steps and a larger coherent distance per day when compared to men.
When separated by age group, this difference was significant only in the older participants.
Additionally, walking speed was significantly higher in women compared to men in the sub-
group of older people.
Conclusions
Age- and sex-specific differences have to be considered when objective gait parameters
are measured, e.g. in the context of clinical risk assessment. For this purpose normative
data, differentiating for age and sex would have to be established to allow reliable classifica-
tion of long-term measurements of gait.
Introduction
The ability to walk is a very important one especially for older people, as it not only allows
them to continue any type of social participation that requires changing locations (e.g. meeting
friends, visiting theater or cinema) but also is an important factor to stay active and healthy.
Walking ability can be compromised by many factors such as joint disorders, muscle weak-
ness, sensomotoric deficits or pain [1]. Functional parameters including walking speed [WS]
or cadence are frequently used to measure walking ability. WS measurements are quick and
easy to perform and have been demonstrated to have a good validity with respect to prediction
of a decline in mobility and high levels of reliability [2,3]. Cesari et al. (2005) conducted a
study with 3.047 well-functioning older adults in which a usual WS of less than 1 m/sec as a
cut-off point was associated with a high risk of developing functional limitations of the lower
extremities, hospitalization and death within the next year [4]. In a systematic review on WS
in geriatric clinical settings, an average speed of 0.58 m/sec at usual walking speed and 0.89 m/
sec at maximum speed could be calculated, demonstrating the mobility limitations of geriatric
patients with medical issues in need of medical intervention [5].
Lower levels of WS have shown to be associated with several chronic conditions such as dia-
betes type 2 hypertension or past fractures [6], and functional status in COPD [7], conditions
typically to be found in older people.
Additionally, in a systematic review by Pamoukdjian et al. (2015), WS was identified as an
independent factor for the identification of older people at risk of frailty as well as an overall
predictor for sarcopenia, disability in activities of daily living (ADL), falls, hospitalization or
institutionalization and mortality [8]. This was confirmed in a systematic review by Clegg et al.
(2015) [9]. In this review, a walking speed of<0.8 m/sec resulted in a 0.99 sensitivity and a
0.64 specificity for identifying older people with frailty. In another systematic review, slow WS
was associated with overall mortality too [10], while in a large population-based cohort study,
overall mortality could be predicted by a walking cadence of less than 100 steps per minute
[11]. In summary, as described in a comprehensive review of the literature by Abellan van Kan
et al. (2009), WS was found to be a consistent risk factor for disability, cognitive impairment,
institutionalization, falls and mortality [12].
While these findings demonstrate the clinical importance of being able to walk at a reason-
able speed, a decline in WS has direct consequences for older people apart from health-related
Long-term gait measurements
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factors. Two UK-based studies exhibited that the majority of two large cohorts of older people
were not able to cross a road safely [13,14]. Thus, it is not surprising that in a cohort of 3,070
older people, slow walking speed and social isolation were found to be associated [15].
WS and cadence can be measured in several ways. The simplest way to measure WS is to
mark a distance on the floor and use a stopwatch to stop the time needed to cover that distance
and to count the number of steps taken. From this, mean walking speed and cadence can be
derived. Goldberg et al. (2011) could demonstrate the validity and minimal detectable change
(MDC) of a 4-meter walking speed test using a stopwatch [16]. However, longer measurement
distances might be able to produce more stable results [17].
A recent publication by Brodie et al (2017) was able to demonstrate that gait characteristics
measured in daily life were able to differentiate between fallers and non-fallers while measure-
ments in a clinical setting were not able to provide this information [18]. This suggests that
walking patterns are influenced by the environment and setting in which measurements take
place. Based on this work, one can argue that measurements in the living environment of par-
ticipants over a longer period of time produces more relevant data and thus should be pre-
ferred to laboratory measurements when applicable. Such measurements require the use of
inertial accelerometric sensors for a continuous capturing of gait characteristics. Additionally,
when using such a measurement protocol, the question arises if established cut-off points for
WS can still be used for interpreting results from long-term measurements of walking speed in
a real-life environment (Real-World Walking Speed, RWWS). Therefore, basic research is
needed to establish normative data on RWWS as well as other gait parameters for different tar-
get populations.
In a publication by Schimpl et al. (2011) [19], a mobile accelerometric system was used to
evaluate the association between walking speed and age in a cohort of middle-aged adults from
the UK who were wearing the accelerometric device for seven consecutive days. Based on this
work, a first data set consisting of RWWS, running steps and total distance per day was pre-
sented to demonstrate the external validity of the measurement system. However, as the cohort
in this study consisted of UK-based blood donors with a wide range of age, data on older adults
as one of several subgroups were limited. Therefore, we conducted a data analysis of a sub-
cohort of the Berlin Aging Study II (BASE-II) using the same sensor as Schimpl and colleagues.
The aim of this analysis was to present data on younger and older adults from a German
cohort using the same measurement approach and to compare these data to those presented
by Schimpl et al. (2011) [19]. We hypothesize therefore that our analysis of RWWS in two
groups of younger and older adults would confirm the findings of Schimpl et al. and thus pro-
vide a broader basis for the use of RWWS as a tool for measuring WS and factors associated
with changes in RWWS in older people.
Materials and methods
The BASE-II was launched to investigate factors associated with “healthy” or “unhealthy”
aging. The cohort was drawn as a convenience sample from the greater metropolitan area of
Berlin, Germany [20,21]. 2,172 participants in two age groups (~75% aged 60–84 years and
~25% aged 20–35 years) were recruited for the medical part of the study. All participants gave
written informed consent and the Ethics Committee of the Charite´—Universita¨tsmedizin Ber-
lin approved the study (approval number EA2/029/09).
A subgroup of 593 participants from the BASE-II study was equipped with a 3-dimensional
accelerometer (actibelt, Trium Analysis Online, Munich; Germany) for a minimum of seven
consecutive days. As this procedure was part of the standard study protocol, all participants
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received written and oral information about the accelerometric measurements as part of the
participation in the main study.
Actibelt tri-axial accelerometer
The actibelt is a tri-axial accelerometer worn near the center of mass of the user with the help
of a belt. The device has a sampling frequency of 100Hz. Battery and memory capacity within
the actibelt RCT1, the model used in this study, allow for continuous measurements of up to
10 days [22]. The trained support vector machine for speed estimation of the actibelt sensor
was successfully validated for the use in populations of healthy individuals in a free-living envi-
ronment using a measurement wheel with a mounted speedometer as reference standard [23].
The measurement wheel provided precise distances and gait speeds for different walking pro-
cedures ranging from deliberately slow walking to running. The results from the reference
standard were the compared with the data of the actibelt accelerometer. For this, step lengths
and number of steps measured with the accelerometer were multiplied to derive measured dis-
tances; furthermore, gait velocity was calculated from these data. To compare these measure-
ments with the reference data, coverage probability (CP) and Lin’s concordance correlation
coefficient (CCC) were calculated. The CP is the proportion of measurements containing the
“true” value of the reference standard while the CCC compares a bivariate set of data to a refer-
ence standard [24]. With the CP should not be lower than 1-α, the CCC can show values
between -1 and +1, with +1 demonstrating “perfect correlation” [25]. In the study by Schimpl
et al. (2001, the CP was 0.99 (0.84–1.0) and the CCC was 00.97 (0.97–0.98) in a model with a
maximum difference of 0.3 m/sec for measured gait speeds. In another study, the actibelt dem-
onstrated a high level of measurement accuracy in patients with multiple sclerosis [26] during
the 6-Minute-walk-test (6MWT), although a slight overestimation of 0.12 to 0.16 m/sec could
be observed in patients with higher levels of disability.
In the BASE-II study, the actibelt sensor monitored the time the sensor was worn and
active, time spent in low, medium and high level physical activity, the number of walking and
running steps, distance covered walking and running, maximum coherent distance covered,
and average speed in walking and running for each day the belt was worn. Additionally, the
average speed during events in which participants covered at least 50 and 100 meters were cal-
culated for each measurement day. From these data, average values over all measurement days,
in which the belt was active and worn for at least 10 hours, were calculated.
Data analysis
Sex, age, height, and BMI were derived from the participant file of the main study for all partic-
ipants wearing the actibelt system. Participants with no available socio-demographic data were
excluded from the analysis. Furthermore, to be considered for the analysis, participants had to
wear the actibelt for at least 2 days for a minimum of 10 hours.
Statistical analysis
Statistical analysis was carried out using the software package SPSS 25 for Windows (IBM Inc.,
Chicago, USA). All interval-scaled data were tested for normal distribution using the Kolmo-
gorov-Smirnov (KS)-test. Based on the results of this test, either mean scores with standard
deviations (SD) or median values with interquartile ranges (IQR) are reported. For comparing
age-related effects on gait, the entire cohort as well as the subgroups of younger and older
adults was analyzed. Additionally, we performed the Mann-Whitney-U-Test for testing signifi-
cant differences between men and women regarding the analyzed gait parameters including a
Bonferroni correction for multiple testing. Furthermore, a multiple linear regression analysis
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was executed for each parameter to test the predictability of these parameters from age, height,
sex and BMI. As part of this regression analysis, an outlier analysis was performed resulting in
the exclusion of four data sets with values beyond the 3-fold SD of the values of all participants.
All statistical tests were performed with a α-level of 0.05 and β = 0.8 unless adapted due to mul-
tiple testing.
Results
554 participants were included into the final analysis, as can be seen in Fig 1. The median of
measurement days was seven days with a range of two to eleven days (IQR 2). 60.7% of the par-
ticipants were male and 39.2% were female. Age, height and BMI were not normally distrib-
uted; therefore, median and IQR values are presented in Table 1.
For all participants as well as for both age groups, no significant differences were found for
age between both sexes. However, both height and BMI were significantly higher in males
when compared to female participants (p<0.001). When comparing sociodemographic data of
the study cohort with the total study population of the BASE II cohort, comparable distribu-
tions of all variables could be obtained with the exception of the proportion of male and female
participants (see Table 1, supporting information).
Table 2 shows the results of the accelerometric measurements. Average data over all
included measurement days on the number of walking steps, maximum coherent distance
walked, total distance walked and gait speed while walking are shown.
All analyzed walking parameters were correlated with age, as can be seen in Fig 2A–2D.
Additionally, group comparisons using the Mann-Whitney-U-test and taking multiple testing
into account (Bonferroni correction for 12 tests resulting in a p-value <0.0042 considered to
be statistically significant) revealed significant differences in respect to the sex of the partici-
pants (Table 2). In the total cohort, the number of walking steps per day and the maximal coher-
ent distance walked were significantly different between men and women. This difference was
only observed in the older group when the two age groups were considered separately
(Table 2).
We calculated a linear regression model for each of the four gait parameters (dependent
variable) including sex, age, height and BMI as independent variables. The models showed
independence of residuals as assessed by Durbin-Watson statistics with values between 1.9 and
Fig 1. Flow diagram of participant inclusion.
https://doi.org/10.1371/journal.pone.0225026.g001
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2.1. All models were able to predict the respective dependent variable, as can be seen in
Table 3.
However, the models were only marginally able to predict the variance in the dependent
variables, as reflected in the low R2-scores. In none of the models, all considered parameters
were contributing significantly to the respective model. Age significantly contributed to pre-
dict the total distance walked per day (p = 0.005) and walking speed (WS) (p<0.001). Sex con-
tributed significantly to the prediction of the number of walking steps per day (p = 0.03) and
walking speed (p< .001), and BMI was able to contribute to the prediction of walking steps,
the maximum coherent distance walked, and the total distance walked per day (all p<0.001).
Further details can be derived from Table 4.
Discussion
The results from our analysis demonstrate a clear inverse association between age and RWWS
and the distance walked per day in a non-selected German population, thereby confirming the
key finding by Schimpl et al. (2011) within a selected UK-based population [19].
While in the group of younger participants RWWS was comparable to the results obtained
by Schimpl et al. (2011) [19], RWWS in the group of older people was lower. Several reasons
might contribute to this observation. The cohort in the study by Schimpl et al. consisted of
blood donors within the NHS Blood and Transplant Service (NHSBT). As such, blood dona-
tions have strict prerequisites in order to protect both the donor and the receiver of the blood
sample. Consequently, any acute disease prohibits blood donation as well as many chronic
conditions such as cardiovascular diseases, stroke, Mb. Parkinson or, in many cases, diabetes
mellitus to name just a few. Additionally, older people cannot donate blood beyond the age of
70. Therefore, it can be assumed that recruitment of the older participants in the study by
Schimpl et al. resulted in a cohort in whom the subgroup of older adults mainly was in a state
Table 1. Sociodemographic variables (n = 554).
Variable All participants Younger participants Older participants
N % N % N %
Sex
Male 337 60.8 67 56.8 270 60.8
Female 217 39.2 51 43.2 166 39.2
Median IQR (Range) Median IQR (Range) Median IQR (Range)
Age (years)
All 67 7 (22–79) 28 5 (22–36) 69 6 (60–79)
Male 67 7 (22–79) 28 3 (22–36) 68 6 (60–80)
Female 67 9 (22–76) 28 6 (22–36) 69 5 (61–76)
Height (cm)�
All 172.8 12.8 (149.2–199.7) 176.2 42.0 (157.7–199.7) 171.7 13.05 (149.2–197.0)
Male 176.4 8.3 (161.5–199.7) 180.1 9.1 (165.1–199.7) 175.7 7.83 (161.5–197.0)
Female 163.7 9.6 (149.2–187.0) 170.0 11.4 (157.7–187.0) 162.6 7.83 (149.2–181.0)
BMI�
All 25.8 5.2 (17.0–43.5) 23.14 4.76 (17.0–40.5) 26.37 4.92 (17.7–43.5)
Male 26.2 4.7 (17.8–42.6) 23.92 4.28 17.8–30.5) 26.71 4.24 (20.0–42.6)
Female 24.5 5.59 (17–43.5) 21.51 5.14 (17.0–40.) 25.33 5.25 (17.7–43.5)
Abr.: BMI: Body Mass Index; IQR: Interquartile Range; N: number of participants
� Significant differences between male and female participants (p<0.001)
https://doi.org/10.1371/journal.pone.0225026.t001
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of very good and as such even better health than the relatively healthy ambulatory participants
of BASE-II. Furthermore, due to the recruitment process the number of participants was very
low in this age group. Therefore, we assume that our results, generated employing a nearly
Table 2. Results of walking parameters (n = 554).
Variable All participants Younger participants Older participants
Median IQR (Range) Median IQR (Range) Median IQR (Range)
Walking steps
All 7831.2 4412.5 (16415.8) 8620.26 4359.0 (15161.1) 7496.07 4493.58 (106.0–20828.3)
Male 7118.4 4456.3 (20686.3) 8209.29 3810.0 (1959.0–17652.8) 6874.15 4424.15 (142.0–20828.3)
Female 8676.7 4113.5 (17983.1) 9352.50 3702.5 (1441.5–18044.1) 8548.09 4123.02 (106.0–17376.2)
MWU-test P < 0.001� P = 0.51 P < 0.001�
Max. coherent distance (meters)
All 846.9 603.1 (6037.1) 995.66 504.8 (355.1–2453.4) 798.7 612.95 (1.0–6038.1)
Male 806.75 675.4 (4940.43) 996.00 578.8 (355.1–2301.1) 761.48 664.63 (5.0–4945.4)
Female 864.50 500.8 (6037.1) 913.38 463.6 (434.6–2453.4) 840.40 501.33 (1.0–6038.1)
MWU-test P = 0.004� P = 0.45 P = 0.004�
Total distance (meters)
All 5589.42 3089.8 (17551.9) 6463.19 2641.1 (1153.0–12532.4) 5206.81 3025.51 (8.0–17559.9)
Male 5251.00 3269.2 (17539.9) 6318.29 2800.5 (1517.0–12524.2) 4825.07 3314.18 (20.0–17559.9)
Female 6015.50 2826.3 (12959.7) 6880.25 2271.8 (1153.0–12532.4) 5782.69 2667.20 (8.0–12967.7)
MWU-test P = 0.24 P = 0.32 P < 0.1
Walking speed (m/sec)
All 1.17 0.11 (0.71) 1.24 0.08 (1.05–1.50) 1.15 0.10 (0.93–1.64)
Male 1.18 0.12 (0.69) 1.25 0.09 (1.09–1.44) 1.16 0.10 (0.95–1.64)
Female 1.16 0.11 (0.57) 1.22 0.09 (1.05–1.50) 1.14 0.10 (0.93–1.45)
MWU-test P = 0.018 P = 0.032 P = 0.019
Abr.: IQR: Interquartile Range; MWU: Mann-Whitney-U-test, N: number of participants
� significant differences between men and women
https://doi.org/10.1371/journal.pone.0225026.t002
Fig 2. A-D: Scatter plots of gait parameters The figures show the gait parameters A) walking steps / day, B)
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identical measurement protocol with the identical type of sensor provide more representative
data especially for older participants as well as a broader data basis for analyzing factors influ-
encing RWWS in older adults. At the same time, the results for RWWS from Schimpl et al.
regarding the younger cohort was verified by our analysis. For this reason, we think that the
results of our analysis underline the general validity and applicability of sensor-based measure-
ments of spatio-temporal gait parameters in the daily living environment of subjects of all age
groups.
Our regression models revealed age as a significant contributor to the total distance covered
per day and the RWWS of the participants. This is also in concordance with the findings by
Schimpl et al. as well as other studies [27]. On the other hand, walking steps/day and the maxi-
mum coherent distance were not significantly associated with age in our cohort. Additionally,
BMI was significantly associated with all gait parameters tested but WS, while height was only
associated with RWWS. As reflected by the low adjusted R2 values, the variance of the depen-
dent variables cannot be explained adequately by the applied regression models based on age,
sex, height and BMI alone. Therefore, we assume that these gait parameters are influenced by
several additional factors not adequately measured in our study. A variety of chronic diseases
is discussed to negatively influence gait speed and walking ability; all with a positively associ-
ated prevalence with age. For example, chronic obstructive pulmonary disease [28] and lower
kidney function [29] have been shown to be associated with lower gait performance. Similar
associations were observed for other chronic diseases such as diabetes or arthritis, but also for
low muscle mass as a defining parameter of sarcopenia [30]. These associations were indepen-
dent of chronic diseases while a combination of both seemed to have the most profound nega-
tive impact on functional performance [30].
Most of these studies, however, focused on single measures, e.g. gait speed, and did not use
long-term measurements of various gait parameters. Future studies therefore need to focus on
the above mentioned and further potential factors to provide analytic models that are able to
predict the consequences of changes in RWWS as well as other gait parameters. Furthermore,
such models should be able to differentiate between individual factors that might be of clinical
importance and environmental factors that can influence walking speed but do not reflect the
individuals’ state of health.
Finally, sex contributed to the models predicting the number of walking steps as well as the
RWWS in the current study. Direct comparisons between men and women in the total cohort
using the Mann-Whitney-U-test showed significant differences for walking steps and the max-
imum coherent distance covered. When comparing men and women in both age groups, no
such differences could be observed in the group of younger participants. In the older cohort,
in contrast, women took significantly more walking steps per day and demonstrated a higher
maximum coherent distance when compared to men. While this, again, suggests that more
factors than age or sex contribute to changes and differences in RWWS, the nonetheless
observable differences especially in the cohort of older adults command some consideration.
Obviously, sex related differences tend to get larger with increasing age. In our cohort, women
took more walking steps per day. While there was a significant difference only for all
Table 3. Model summary for the analyzed variables.
Dependent variable F Adj. R2 p
Walking steps (3, 549) = 18.59 .113 < .001�
Max. coherent distance (3, 549) = 4.84 .027 .001�
Max. distance (3, 549) = 18.80 .114 < .001�
Gait speed (3, 549) = 34.39 .195 < .001�
https://doi.org/10.1371/journal.pone.0225026.t003
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participants and older participants, the effect was observable as a trend in the younger cohort
too and became more pronounced in the group of older adults. The same pattern was observed
in all other evaluated parameters, although the direction of this was reversed in walking speed.
Therefore, we conclude that sex-related differences exist in gait-related measurements that
should be taken into account when interpreting results in future studies. However, as the
mechanism behind the observed differences both for age and sex as of now remains largely
unclear, the need to further examine these factors more deeply is obvious. As the sensor itself
was tested against a gold standard in a comprehensive validation study [23], we deem the abil-
ity of the sensor to measure gait in real life from a purely technical standpoint as valid. On the
other side, questions remain on how to interpret measurements of RWWS in older people.
This includes which factors are contributing to a decline of RWWS-related parameters and
how to use these factors in early detection of risk factors associated with older age. In this,
some factors might contribute to gait characteristics gathered in real-life that have to be taken
into account more thoroughly. One of the inclusion criteria for our analysis was that the acti-
belt sensor had to be worn at least 10 hours per day. We had, however, no exact information
on the level of activity participants were exhibiting when the belt was not worn. So, it might be
possible that the sensor was donned at either times of high activity or leisure time while keep-
ing it off at other activities, leading to a bias of our overall results. While we can assume to a
certain degree that such a potential bias has been evened out based on the size for our sample,
especially the maximum coherent distance measured each day seems to be more prone to a
measurement bias induced by the wearing times in comparison to the other parameters used
in this analysis. In this, a potential analysis of wearing times would not have revealed the levels
of activity during times the belt was not worn. For this reason, we did not pursue to include
Table 4. Regression analysis for walking steps, maximum coherent distance, total distance and gait speed.
Variable B SEB β p
Walking steps (m) Intercept 13810.92 4537.07
sex 850.51 390.28 .122 .030�
Age (years) -10.13 9.08 -.050 .265
Height cm) -.744 22.01 -.002 .973
BMI (kg/m2) -236.20 34.97 -.287 < .001�
Maximum coherent distance (m) Intercept 1026.07 889.25
sex 25.49 76.49 .020 .739
Age (years) -1.17 1.78 -.031 .512
Height cm) 3.69 4.31 .052 .392
BMI (kg/m2) -24.80 6.86 -.161 < .001�
Total distance (m) Intercept 10000.76 3364.94
sex 320.46 289.45 .062 .269
Age (years) -18.92 6.74 -.125 .005�
Height cm) 4.78 16.32 .017 .770
BMI (kg/m2) -166.61 25.94 -.273 < .001�
Gait speed (m/sec) Intercept 1.642 .117
sex -0.35 .010 -0.185 .001�
Age (years) -0.03 .000 -.475 .000�
Height cm) -.002 .001 -.152 .006�
BMI (kg/m2) .000 .001 .015 .713
Abr.: B: unstandardized regression coefficient; SEB: Standard of the coefficient; β: standardized coefficient; p: statistical significance (� = significant contributor)
https://doi.org/10.1371/journal.pone.0225026.t004
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this factor in our analysis. Therefore, more detailed information on wearing times and accom-
panied activities are warranted in future studies.
The median RWWS calculated in our analysis is comparable to the gait speed values
reported by Cesari et al. (2005) [4]. However, WS reported in other publications demonstrated
a high variability on the obtained values. Samson et al. (2001) reported values of more than 1.3
m/sec in healthy older adults of 60 years or older [31]. In two systematic reviews reporting WS
for older people in hospital settings or long-term care facilities, much slower WS values were
reported. While Peel et al. (2012) calculated a mean WS of 0.58 m/sec for usual WS and 0.89
m/sec for maximal WS when pooling all WS data of the included studies [5], usual WS in the
review conducted by Kuys et al (2014), the included studies exhibited between 0.14 and 0.92
m/sec [32]. Both studies reported a variety of measurement regimes with distances between 4
and 20 meters. Such variances could be explained by a study that could demonstrate how dif-
ferences in testing protocols for measuring WS could lead to different results [33]. While this
shows potential difficulties in comparing scientific results on WS, it also shows how situational
changes and the setting in which the measurements take place can affect results of walking and
mobility assessments. In another study, different focusing strategies for detecting obstacles
during walking tasks could be observed in fallers and non-fallers [34]. Obstacle recognition
and deriving appropriate strategies to avoid them can interfere with activity-related goals in
daily life and thus can influence the overall walking speed in the real-life environment of older
people. All these factors can contribute to a lower RWWS in older adults who are capable,
from a purely functional and physiological standpoint, to walk at a faster pace. This is also
illustrated by a recent analysis of BASE-II data, where we found the subjective age of partici-
pants well correlated with the results of mobility measurements in a laboratory setting, but not
with RWWS measured in daily life [35]. Other potential factors influencing walking speed can
be slippery or unstable surfaces that make an adaption of the walking strategy necessary
[36,37] or exhibit effects on walking speed over time, e.g. getting slower after a certain time or
distance traveled due to pain or exhaustion. Again, the additional impact of chronic diseases
like diabetes or peripheral arterial occlusive disease on the ability to adapt to external and situ-
ational factors such as changes in ground surface have to be considered as well.
In our estimation and expectation, these situational factors will play a significant role when
WS is measured over a longer period of time and within the living environment of the partici-
pants. It can be expected that measuring RWWS with a body worn sensor will measure WS in
many different situations of everyday life and thus encompasses many factors influencing WS
in both directions. Thus, the RWWS could be a much more realistic parameter for evaluating
the walking ability of older people than laboratory conditions. It can be assumed that this kind
of influence can be found for other gait-related parameters as well.
Therefore, an urgent demand for gait-related research is warranted where standard mea-
surements of gait in laboratory settings are compared to real life and long-term measurements.
Ideally, such comparisons would take into account different situations in which external fac-
tors have an influence on walking speed and other mobility parameters. This would enable
researchers to take a more in-depth look at how walking as a physical function and an everyday
ability represents different dimensions of mobility and, subsequently, how measurements of
either kind can be used to derive more precise and specific implications for risk stratification,
physical therapy, prevention and rehabilitation; and other fields of patient care of older people.
Conclusion
Both age and sex contribute to differences in the absolute values of gait-related parameters.
Therefore, any interpretation and clinical decisions based on the results of gait measurements
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have to take into account both these variables. In order to be able to derive valid conclusions,
normative values for meaningful differences in RWWS measurements with respect to age and
sex have to be established. Such normative values may enhance the value of absolute values of
RWWS measurements in prediction of functional decline as well as the onset of age-related
chronic conditions in older people.
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